You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: exercise training delays death and hospital admission in chronic heart failure

https://doi.org/10.1136/ebm.9.5.137

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Piepoli MF, Davos C, Francis DP, et al. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 2004;328:189–92.
    OpenUrlAbstract/FREE Full Text

    
 
 Q In patients with chronic heart failure (CHF) resulting from left ventricular systolic dysfunction, does exercise training reduce death or admission to hospital?

    Clinical impact ratings GP/FP/Primary care ★★★★★★☆ IM/Ambulatory care ★★★★★★☆ Cardiology ★★★★★☆☆

    METHODS

    Embedded ImageData sources:

    Medline; Cochrane Reviews database; reference lists; abstracts presented at scientific meetings and published in Circulation, Journal of the American College of Cardiology, or European Heart Journal; and contact with researchers.

    Embedded ImageStudy selection and assessment:

    randomised controlled trials (RCTs) from 1990 on that evaluated exercise training (without any other simultaneous intervention) in patients who had CHF for ⩾3 months (resulting from left ventricular systolic dysfunction). The exercise programme had to last ⩾8 weeks and involve at least both legs. Individual patient data from all RCTs were entered into a master database for analysis.

    Embedded ImageOutcomes:

    death at ⩾3 months and hospital admission.

    MAIN RESULTS

    9 RCTs (8 from Europe) met the selection criteria. Sample size ranged from 27–181 …

    View Full Text

    Footnotes

    • For correspondence: Dr M F Piepoli, Royal Brompton Hospital, London, UK. m.piepoliimperial.ac.uk

    • Source of funding: Royal Brompton and Harefield NHS Trust Clinical Research Committee.